Raymond James Reiterates Outperform Rating on Alignment Healthcare, Inc. (ALHC)

Market Context

Alignment Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $14.56 with a market capitalization of $3.8B.

Analyst coverage from Raymond James provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Alignment Healthcare, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Alignment Healthcare, Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 03, 2026	Raymond James	Outperform	N/A
May 26, 2026	Barclays	Equal-Weight	N/A
May 01, 2026	UBS	Neutral	N/A
May 01, 2026	Barclays	Equal-Weight	N/A
Feb 05, 2026	JP Morgan	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View ALHC Stock Page